Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.

L Parker GreggDavid J RamseyJulia M AkeroydShehrezade A JafryMichael E MathenySalim S ViraniSankar D Navaneethan

Published in: American journal of kidney diseases : the official journal of the National Kidney Foundation (2023)

Prescription for SGLT2i was low among likely eligible patients, with evident disparities by sex and race and between individual VA facilities. Efforts are needed to study and address the reasons for these disparities to improve equitable adoption of these important medications.

Keyphrases

affordable care act
chronic kidney disease
electronic health record
quality improvement
health insurance